Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders

Authors:

Abstract
No abstract available
Funding Information
  • H2020 Marie Skłodowska-Curie Actions (101031962)
  • H2020 Marie Skłodowska-Curie Actions (01031317)
  • Infectious Diseases Society of America Foundation
  • Brain and Behavior Research Foundation (26826)

This publication has 144 references indexed in Scilit: